Optimal side-branch stenting strategy for complex coronary bifurcation using drug-coated balloons
Official title: Drug-Coated Balloon Versus Drug-eluting Stent for Treatment of Clinically Relevant Side Branch in Complex Coronary Bifurcation Lesion
Run by Samsung Medical Center · NCT07019350 · Data updated 2026-11-12
This study tests whether starting with two stents or using a drug-coated balloon (DCB)-based hybrid approach works better for adults having PCI for complex coronary bifurcation lesions with an important side branch.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 520 (estimated) |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 3 sites (Gwangju and 2 other locations) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | November 24, 2025 |
| Trial ID | NCT07019350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥19 years) with acute or chronic coronary syndrome planned for PCI who have de novo true coronary bifurcation lesions with a clinically relevant side branch (Medina 1,1,1; 1,0,1; 0,1,1) with SB lesion length ≥10 mm and meeting the protocol's stenosis/size criteria, and who can give informed consent are ideal candidates.
✕Probably not a fit
Patients who are hemodynamically unstable, who do not have a true or clinically significant side-branch lesion, who have very small side branches that do not meet size criteria, or who are not PCI candidates are unlikely to benefit from this trial's treatments.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multi-center, open-label, randomized controlled superiority trial comparing an upfront two-stent strategy versus an upfront DCB-based hybrid strategy in patients with complex true coronary bifurcation lesions. Eligible lesions are true bifurcations (Medina 1,1,1; 1,0,1; 0,1,1) with side-branch lesion length ≥10 mm and defined severity/size thresholds for left main and non-left main vessels. The study enrolls adults undergoing PCI for acute or chronic coronary syndromes and measures clinical outcomes such as mortality, unplanned repeat revascularization, and stent-related complications. The trial builds on mixed prior results favoring two-stent approaches in more complex lesions and emerging data supporting DCB angioplasty at side branches.
Why it matters
Potential benefit: If successful, the approach could reduce the need for repeat procedures and lower stent-related complications for patients with complex bifurcation lesions.
How similar studies have gone: Previous trials have shown mixed results—some favor upfront two-stent strategies for very complex bifurcations, while recent studies of DCB use at side branches have produced promising but not yet definitive results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Subject must be at least 19 years of age * Patients with acute or chronic coronary syndrome intended for percutaneous coronary intervention (PCI) * Patients with de novo complex coronary bifurcation with clinically relevant side branch. Definition of complex coronary bifurcation with clinically relevant side branch is true bifurcation lesion (Medina 1,1,1 / 1,0,1 / 0,1,1) with side branch lesion length ≥10mm and should meet at least one of the below criteria. i. Left main bifurcation with side branch stenosis severity ≥70% by visual estimation ii. Non-left main bifurcation with side branch reference vessel diameter ≥2.75mm and stenosis severity ≥90% by visual estimation * Subject who can verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive approach and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure. Exclusion Criteria * Hemodynamically unstable condition (SBP \<90 mmHg even after administration of vasopressor, ventricular arrhythmias, or cardiogenic shock) * Known true anaphylaxis to contrast medium (not allergic reaction but anaphylactic shock) * Known significant congenital, severe valvular or cardiomyopathic (hypertrophic or dilated cardiomyopathy, or any other forms) process which could explain cardiac symptoms. * Severe left ventricular systolic dysfunction (ejection fraction \<30%) * Intolerance to aspirin, clopidogrel, ticagrelor, prasugrel, or heparin. * Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment) * Unwillingness or inability to comply with the procedures described in this protocol.
Where it's running
-
Samsung Medical Center
Seoul, South Korea Recruiting -
Chonnam National University Hospital
Gwangju, South Korea Not yet recruiting -
Chosun University Hospital
Gwangju, South Korea Not yet recruiting
Study contacts
- Principal investigator: Young Bin Song, MD, PhD — Samsung Medical Center
- Study coordinator: Young Bin Song, MD, PhD
- Email: youngbin.song@gmail.com
- Phone: 82-2-3410-2575
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.